Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Platelet-Based Dose-Adjusted Low Molecular Weight Heparin Treatment Is Efficacious and Safe in Newly Diagnosed Acute Leukemia Patients with Catheter-Related Thrombosis

Shay Perek, Niv Izhaki, Benjamin Brenner, Tamar Katz, Netanel A. Horowitz

Blood (2023) 142 (Supplement 1): 4027.

https://doi.org/10.1182/blood-2023-185544

Published: 2023

Journal Articles

Myeloid-Derived Suppressor Cells As Potential Contributors to Pregnancy-Associated Lymphoma Progression

Netanel A Horowitz, MD, Noam Bettman, PhD, Ali Abd El Wahed, Tamar Katz, PhD

Blood (2019) 134 (Supplement_1): 3979.

https://doi.org/10.1182/blood-2019-124292

Published: 2019

Journal Articles

Brief Ex Vivo Incubation with Fas Ligand Selectively Depletes Alloreactive T Cells and Antigen Presenting Cells from Stem Cell Grafts

Hilit Levy-Barazany, PhD, Liat Pinkas, PhD, Galina Rodionov, Nitzan Marelly, Michal Tzadok, Hila Wildbaum, Tamar Katz, PhD, Ronit Bakimer, PhD, Shai Yarkoni, MD PhD, Amnon Peled, Jerry Stein, MD, Tsila Zuckerman, MD

Blood (2018) 132 (Supplement 1): 2033.

https://doi.org/10.1182/blood-2018-99-117920

Published: 2018

Journal Articles

A Simple Model for Predicting Post-Autologous Stem Cell Transplantation Outcome in Patients with Relapsed/Primary Refractory Hodgkin Lymphoma

Eldad J Dann, MD, Shani Sobol, Tania Mashiach, Tamar Katz, PhD, Tsila Zuckerman, MD

Blood (2018) 132 (Supplement 1): 2150.

https://doi.org/10.1182/blood-2018-99-110713

Published: 2018

Journal Articles

Results of a Non-Interventional Clinical Trial of Apograft — a Novel Technology for GvHD Prevention

Jerry Stein, MD, Tsila Zuckerman, MD, Yuval Baar, Hila Wildbaum, Tamar Katz, Michal Perl-Yaffe, Limor Horev-Azaria, Shai Yarkoni, MD PhD, Amotz Nechushtan, Galina Rodionov, Liron Gez, Michal Rosenzwaig, Anastasia Rodin, Yaron Pereg, John F DiPersio, MD PhD, Jacob M. Rowe, MD, Isaac Yaniv, MD

Blood (2017) 130 (Supplement 1): 4445.

https://doi.org/10.1182/blood.V130.Suppl_1.4445.4445

Published: 2017

Journal Articles

Chronic Lymphocytic Leukemia Cells Exhibit Inhibitory Properties of Regulatory B Cells

Shimrit Ringelstein-Harlev, MD, Irit Avivi, MD, Lina Bisharat, Tamar Katz, Ph.D

Blood (2012) 120 (21): 3874.

https://doi.org/10.1182/blood.V120.21.3874.3874

Published: 2012

Journal Articles

Contribution of Decreased Migration of Monocytes to Impaired Inflammation in Gaucher Disease

Tamar Katz, Ph.D, Noam Bettman, MSc., Hanna Rosenbaum, MD, Irit Avivi, MD

Blood (2011) 118 (21): 2162.

https://doi.org/10.1182/blood.V118.21.2162.2162

Published: 2011

Journal Articles

Increased Incidence of Autoimmune and Lymphoproliferative Disorders in Gaucher Patients Accompanied with Significantly Impaired Dendritic Cell Function,

Hanna Rosenbaum, MD, Noam Bettman, MSc., Tamar Katz, Ph.D, Irit Avivi, MD

Blood (2011) 118 (21): 3211.

https://doi.org/10.1182/blood.V118.21.3211.3211

Published: 2011

Journal Articles

Rituximab Directly Decreases T Cell Activation, Both In Vivo and In Vitro

Tamar Katz, PhD, Dina Stroopinsky, PhD, Jacob M. Rowe, MD, Irit Avivi, MD

Blood (2010) 116 (21): 3935.

https://doi.org/10.1182/blood.V116.21.3935.3935

Published: 2010

Journal Articles

Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies – A Curative Approach When Performed as a Primary Therapeutic Modality: A Single Center Experience.

Ronit Elhasid, MD, Irina Zaidman, MD, Abdalla Khalil, MD, Tsila Zuckerman, MD, Nuhad Haddad, MD, Tamar Katz, Ph.D, Myriam Ben Arush, MD, Jacob M. Rowe, MD

Blood (2009) 114 (22): 1144.

https://doi.org/10.1182/blood.V114.22.1144.1144

Published: 2009

Journal Articles

Allogeneic Stem Cell Transplantation (ASCT) in CML with Partial T-Cell Depletion, No Prophylaxis for Graft-Versus-Host Disease (GvHD) and Preemptive DLI for Patients with Post-Transplant Minimal Residual Disease (MRD): An Alternative Approach in CML Transplantation with Low Morbidity and Long Term Disease Free Survival.

Tsila Zuckerman, MD, Tamar Katz, PhD, Nuhad Haddad, MD, Riva Fineman, MD, Irit Avivi, MD, Eldad J. Dann, MD, Dvora Sahar, PhD, Ana Oliven, MSc, Ety Hertz, Yishay Ofran, MD, Luiza Akria, MD, Michal Markovitz, Tal Faibish, MSc, Jacob M. Rowe, MD

Blood (2006) 108 (11): 318.

https://doi.org/10.1182/blood.V108.11.318.318

Published: 2006

NARROW

Platelet-Based Dose-Adjusted Low Molecular Weight Heparin Treatment Is Efficacious and Safe in Newly Diagnosed Acute Leukemia Patients with Catheter-Related Thrombosis

Myeloid-Derived Suppressor Cells As Potential Contributors to Pregnancy-Associated Lymphoma Progression

Brief Ex Vivo Incubation with Fas Ligand Selectively Depletes Alloreactive T Cells and Antigen Presenting Cells from Stem Cell Grafts

A Simple Model for Predicting Post-Autologous Stem Cell Transplantation Outcome in Patients with Relapsed/Primary Refractory Hodgkin Lymphoma

Results of a Non-Interventional Clinical Trial of Apograft — a Novel Technology for GvHD Prevention

Chronic Lymphocytic Leukemia Cells Exhibit Inhibitory Properties of Regulatory B Cells

Contribution of Decreased Migration of Monocytes to Impaired Inflammation in Gaucher Disease

Increased Incidence of Autoimmune and Lymphoproliferative Disorders in Gaucher Patients Accompanied with Significantly Impaired Dendritic Cell Function,

Rituximab Directly Decreases T Cell Activation, Both In Vivo and In Vitro

Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies – A Curative Approach When Performed as a Primary Therapeutic Modality: A Single Center Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only